Clinical Trial Update: Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update describing a study of Iparomlimab and Tuvonralimab for untreated locally advanced nasopharyngeal squamous cell carcinoma, not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Locally Advanced Nasopharyngeal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING